Calprotectin Leaders BDC operates in a market with the broadest calprotectin product range including fCAL and sCAL turbo assays, offering an opportunity to upsell integrated calprotectin solutions to clinical and research labs seeking streamlined testing.

N. American Presence As the North American affiliate of a global leader, BDC can leverage closer customer relationships and enhanced support to cross-sell BÜHLMANN specialty assays (Cellular Allergy, GanglioCombi, Chronobiology melatonin) to existing regional customers and expand adoption.

Niche Portfolio BDC’s unique offerings in neuroimmunology, anti-ganglioside screening, and calprotectin sampling devices position it to pursue targeted labs and hospitals needing specialized panels, enabling selective upsell of complementary assays and consumables.

Growth Funding Signal With reported revenue between one and ten million dollars, there is room for sales acceleration through bundled kits, expanded distribution, and service contracts aimed at mid-size clinical labs and research sites evaluating new biomarkers.

Digital Engagement Active tech stack and online presence (Shopify, WordPress, Salesforce, Drift) support scalable lead generation, e-commerce purchases of assay kits, and proactive post-sale support, suggesting opportunities for digital marketing campaigns and customer success programs.